These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15654751)

  • 1. The aromatic domain of the coronavirus class I viral fusion protein induces membrane permeabilization: putative role during viral entry.
    Sainz B; Rausch JM; Gallaher WR; Garry RF; Wimley WC
    Biochemistry; 2005 Jan; 44(3):947-58. PubMed ID: 15654751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of a peptide from the pre-transmembrane domain of the severe acute respiratory syndrome coronavirus spike protein with phospholipid membranes.
    Guillén J; Moreno MR; Pérez-Berna AJ; Bernabeu A; Villalaín J
    J Phys Chem B; 2007 Dec; 111(49):13714-25. PubMed ID: 18020324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct evidence that the N-terminal heptad repeat of Sendai virus fusion protein participates in membrane fusion.
    Ghosh JK; Shai Y
    J Mol Biol; 1999 Sep; 292(3):531-46. PubMed ID: 10497019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein.
    Sainz B; Rausch JM; Gallaher WR; Garry RF; Wimley WC
    J Virol; 2005 Jun; 79(11):7195-206. PubMed ID: 15890958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane-induced step in the activation of Sendai virus fusion protein.
    Ben-Efraim I; Kliger Y; Hermesh C; Shai Y
    J Mol Biol; 1999 Jan; 285(2):609-25. PubMed ID: 9878433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors contributing to the fusogenic potency of foamy virus.
    Epand RM; Epand RF
    Biochem Biophys Res Commun; 2001 Jun; 284(4):870-4. PubMed ID: 11409874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex.
    Bosch BJ; van der Zee R; de Haan CA; Rottier PJ
    J Virol; 2003 Aug; 77(16):8801-11. PubMed ID: 12885899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core structure of S2 from the human coronavirus NL63 spike glycoprotein.
    Zheng Q; Deng Y; Liu J; van der Hoek L; Berkhout B; Lu M
    Biochemistry; 2006 Dec; 45(51):15205-15. PubMed ID: 17176042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusion peptides and transmembrane domains of fusion proteins are characterized by different but specific structural properties.
    Weise K; Reed J
    Chembiochem; 2008 Apr; 9(6):934-43. PubMed ID: 18330852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A leucine zipper motif in the ectodomain of Sendai virus fusion protein assembles in solution and in membranes and specifically binds biologically-active peptides and the virus.
    Ghosh JK; Ovadia M; Shai Y
    Biochemistry; 1997 Dec; 36(49):15451-62. PubMed ID: 9398274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the N-terminal heptad repeat of HIV-1 in the actual lipid mixing step as revealed by its substitution with distant coiled coils.
    Wexler-Cohen Y; Sackett K; Shai Y
    Biochemistry; 2005 Apr; 44(15):5853-61. PubMed ID: 15823044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of histidine residues in low-pH-mediated viral membrane fusion.
    Kampmann T; Mueller DS; Mark AE; Young PR; Kobe B
    Structure; 2006 Oct; 14(10):1481-7. PubMed ID: 17027497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide models for the membrane destabilizing actions of viral fusion proteins.
    Epand RM; Cheetham JJ; Epand RF; Yeagle PL; Richardson CD; Rockwell A; Degrado WF
    Biopolymers; 1992 Apr; 32(4):309-14. PubMed ID: 1623124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrophobic alpha-helices 1 and 2 of herpes simplex virus gH interact with lipids, and their mimetic peptides enhance virus infection and fusion.
    Gianni T; Fato R; Bergamini C; Lenaz G; Campadelli-Fiume G
    J Virol; 2006 Aug; 80(16):8190-8. PubMed ID: 16873275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basis for fusion inhibition by peptides: analysis of the heptad repeat regions of the fusion proteins from Nipah and Hendra viruses, newly emergent zoonotic paramyxoviruses.
    Xu Y; Gao S; Cole DK; Zhu J; Su N; Wang H; Gao GF; Rao Z
    Biochem Biophys Res Commun; 2004 Mar; 315(3):664-70. PubMed ID: 14975752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A heptad repeat in herpes simplex virus 1 gH, located downstream of the alpha-helix with attributes of a fusion peptide, is critical for virus entry and fusion.
    Gianni T; Menotti L; Campadelli-Fiume G
    J Virol; 2005 Jun; 79(11):7042-9. PubMed ID: 15890943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR structures and localization of the potential fusion peptides and the pre-transmembrane region of SARS-CoV: Implications in membrane fusion.
    Mahajan M; Bhattacharjya S
    Biochim Biophys Acta; 2015 Feb; 1848(2):721-30. PubMed ID: 25475644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual topological arrangement of structural motifs in the baboon reovirus fusion-associated small transmembrane protein.
    Dawe S; Corcoran JA; Clancy EK; Salsman J; Duncan R
    J Virol; 2005 May; 79(10):6216-26. PubMed ID: 15858006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heptad repeat 2 in herpes simplex virus 1 gH interacts with heptad repeat 1 and is critical for virus entry and fusion.
    Gianni T; Piccoli A; Bertucci C; Campadelli-Fiume G
    J Virol; 2006 Mar; 80(5):2216-24. PubMed ID: 16474129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acids can substitute the HIV fusion peptide in lipid merging and fusion: an analogy between viral and palmitoylated eukaryotic fusion proteins.
    Lev N; Shai Y
    J Mol Biol; 2007 Nov; 374(1):220-30. PubMed ID: 17919659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.